Compound ID | 814
Class: Oxazolidinone
Spectrum of activity: | Gram-positive |
Institute where first reported: | Pharmacia Corp. (Pfizer, USA) |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citation: |